Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bone Sarcomas Behavior Behavioral Symptoms Bone Diseases Bone Neoplasms Financial Stress Financial Toxicity Musculoskeletal Diseases Neoplasms Neoplasms by Site Stress, Psychological

Sex eligibility

All sexes

Study type

Observational

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Shalin S Patel, MD

CONTACT

[email protected]

713-792-6268

Shalin S Patel, MD

PRINCIPAL_INVESTIGATOR

About this study

Measure the prevalence of financial toxicity and the severity of it in orthopaedic oncology patients undergoing surgical intervention using an objective, validated instrument. Secondary objectives include identifying socioeconomic and demographic risk factors for financial toxicity and evaluating clinicopathologic characteristics that may worsen financial stress in this population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
  • Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.

Exclusion criteria

  • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.

Treatment and study plan

Data Collection

Other

data collection from electronic health records

Primary outcomes

  1. Questionnaires

    Time frame: Through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Shalin S Patel, MD

CONTACT

[email protected]

713-792-6268

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2028
Study completion
2030
First posted
Oct 10, 2025
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.